Dysfunctional changes in physiological functioning, psychological
functioning, mood state, cognitive
process, or all of these, as a
consequence of consumption of [phencyclidine]; usually disruptive, and
often stemming from central nervous system impairment.*
Diagnostic criteria for 292.89 Phencyclidine Intoxication
(cautionary statement)
A. Recent use of phencyclidine (or a related substance).
B. Clinically significant maladaptive behavioral changes (e.g., belligerence,
assaultiveness, impulsiveness, unpredictability, psychomotor
agitation, impaired judgment, or impaired social or occupational functioning) that developed during, or shortly after, phencyclidine use.
C. Within an hour (less when smoked, "snorted," or used intravenously), two (or more) of the following signs:
(1) vertical or horizontal nystagmus
(2) hypertension or tachycardia
(3) numbness or diminished responsiveness to pain
(4) ataxia
(5) dysarthria
(6) muscle rigidity
(7) seizures or coma
(8) hyperacusis
D. The symptoms are not due to a general medical condition and are not better accounted for by another
mental disorder.
Specify if:
With Perceptual Disturbances
Reprinted with permission from the Diagnostic
and Statistical Manual of Mental Disorders, fourth Edition. Copyright 1994 American
Psychiatric Association
|
Books and Other
Media:
Follow the hypertext link to purchase items. |
 |
-
 
Friday Ice Cube, Chris Tucker, Nia Long, Tommy 'Tiny' Lister 1995
*Excerpt with permission from Graham, Allan W. & Schultz, Terry K.
(Editors)
Principles of Addiction Medicine, 2nd Edition
Hardcover 1998 (American Society of Addiction Medicine)
|
